 Treatment Outcome
"Treatment Outcome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
| Descriptor ID |
D016896
|
| MeSH Number(s) |
E01.789.800 N04.761.559.590.800 N05.715.360.575.575.800
|
| Concept/Terms |
Clinical Effectiveness- Clinical Effectiveness
- Clinical Effectivenesses
- Effectiveness, Clinical
- Effectivenesses, Clinical
- Patient-Relevant Outcome
- Outcome, Patient-Relevant
- Outcomes, Patient-Relevant
- Patient Relevant Outcome
- Patient-Relevant Outcomes
- Clinical Efficacy
- Efficacy, Clinical
|
Below are MeSH descriptors whose meaning is more general than "Treatment Outcome".
Below are MeSH descriptors whose meaning is more specific than "Treatment Outcome".
This graph shows the total number of publications written about "Treatment Outcome" by people in this website by year, and whether "Treatment Outcome" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 30 | 30 | | 1997 | 0 | 48 | 48 | | 1998 | 0 | 54 | 54 | | 1999 | 1 | 42 | 43 | | 2000 | 0 | 65 | 65 | | 2001 | 1 | 76 | 77 | | 2002 | 1 | 76 | 77 | | 2003 | 1 | 126 | 127 | | 2004 | 1 | 138 | 139 | | 2005 | 4 | 172 | 176 | | 2006 | 1 | 193 | 194 | | 2007 | 2 | 199 | 201 | | 2008 | 1 | 230 | 231 | | 2009 | 3 | 259 | 262 | | 2010 | 2 | 300 | 302 | | 2011 | 1 | 340 | 341 | | 2012 | 0 | 338 | 338 | | 2013 | 3 | 398 | 401 | | 2014 | 4 | 454 | 458 | | 2015 | 1 | 440 | 441 | | 2016 | 1 | 418 | 419 | | 2017 | 5 | 524 | 529 | | 2018 | 5 | 525 | 530 | | 2019 | 4 | 479 | 483 | | 2020 | 3 | 462 | 465 | | 2021 | 5 | 391 | 396 | | 2022 | 0 | 377 | 377 | | 2023 | 0 | 317 | 317 | | 2024 | 0 | 453 | 453 | | 2025 | 0 | 452 | 452 | | 2026 | 0 | 95 | 95 |
To return to the timeline, click here.
Below are the most recent publications written about "Treatment Outcome" by people in Profiles.
-
Sharp J, Strati P, Bhatta S, Huang JJ, Thomas C, Elghawy O, Reef D, Gorzewski A, Wang J, Shouse G, Reinert C, Teferra A, Velez ET, Pelcovits A, Ollila T, Clark W, Yazbeck V, Maakaron J, Kamdar M, Fitzgerald L, Danilov A, Karmali R, Grover NS, Barta SK, Voorhees TJ, Chen AI, Shadman M, Ahmed S, Epperla N. Real-world outcomes and toxicities of CAR-T in relapsed/refractory follicular lymphoma: a multicenter cohort study. Blood Adv. 2026 Jun 09; 10(11):3757-3768.
-
Costa TA, de Sousa LMT, Nogueira A, Chagas GCL, Abreu M, Allen LA, Cornwell WK, Harrington J. Association between SGLT2 inhibitors and outcomes after heart transplant in patients with type 2 diabetes: A systematic review and meta-analysis. Heart Fail Rev. 2026 Jun 06; 31(1).
-
Huddleston H, Martinez J, Cook J, Trapp M, Chen NC, Schwander K, Moss S, Palkimas S. Assessing the impact of pharmacist-led interventions on glucagon-like peptide 1 receptor agonist access and treatment outcomes. J Manag Care Spec Pharm. 2026 Jun; 32(6):651-659.
-
Hemendinger E, Thompson JA, Fishman J, Sinsko K, Gebhardt H, Davis RA. Beyond the Numbers: Quantitative and qualitative analysis of quality of life after deep brain stimulation for OCD. PLoS One. 2026; 21(5):e0350293.
-
Limbrick DD, Shannon CN, Bayman EO, Meehan T, Kallem M, Ackerman LL, Adelson PD, Ahmed R, Albert G, Aldana PR, Alden TD, Anderson RCE, Baird LC, Bauer D, Bethel-Anderson T, Bierbrauer K, Brockmeyer DL, Chern JJ, Couture DE, Daniels DJ, Dauser RC, Dlouhy BJ, Durham SR, Ellenbogen RG, Eskandari R, Gannon SR, Grant GA, Graupman PC, Greenberg JK, Greene S, Greenfield JP, Gross NL, Guillaume DJ, Hankinson TC, Heuer G, Iantosca M, Iskandar BJ, Jackson EM, Jallo GI, Johnston JM, Keating RF, Kelly MP, Kennedy E, Krieger MD, Kulkarni AV, Labuda R, Leonard JR, Maher CO, Mangano FT, McComb JG, McEvoy SD, McKinstry RC, Menezes AH, Niazi TN, Oakes J, Olavarria G, O'Neill BR, Poppe D, Ragheb J, Reeves S, Reynolds L, Selden NR, Shah MN, Shimony JS, Smyth MD, Spears S, Stone SSD, Strahle JM, Tamber M, Tramelli G, Tuite GF, Tyler-Kabara EC, Vance H, Wait SD, Wellons JC, Whitehead WE, Yahanda AT, Yan Y, Dacey RG, Park TS, Torner JC. Decompression with or without Duraplasty for Chiari I and Syringomyelia. N Engl J Med. 2026 May 28; 394(20):2015-2025.
-
Gibson NM, Nguyen N, Amaral S, Hsu J, Haney M, Heimbruch KE, Sabulski A, Zurawel A, Davidow KA, Lind KT, Scanlon S, Alva H, Hall L, Bailey LC, Olson TS, Kwiatkowski JL. Impact of iron overload on hematopoietic stem cell transplantation in pediatric patients with nonmalignant hematological disorders. Blood Adv. 2026 May 26; 10(10):3324-3334.
-
Bansal A, Stoffel EM, Lim R, Stanich PP, Patel SG, Burke CA, Hall MJ, Singh A, Boardman LA, Samadder NJ, Ballestar V, Muller C, Scott AJ, Benante KA, Xu Y, Eickhoff J, Hyun M, Zaborek J, Aquila L, Umar A, Szabo E, Della'Zanna G, Richmond E, Bengtson L, Schlom J, Donahue RN, Toney NJ, Horn LA, Palena C, Gulley JL, Samaddar S, Moore DF, Sharma P, Madan R, Hurley KE, Soon-Shiong P, Gabitzsch E, Sender L, Brenner D, Schuetze S, Djuric Z, Barroilhet LM, Thompson P, Bauman J, Khan SA, Vilar E. Design and preliminary report of a randomized phase IIb clinical trial of multitargeted recombinant adenovirus 5 vaccines against CEA, MUC1, and brachyury (Tri-Ad5) and the IL-15 receptor superagonist nogapendekin alfa inbakicept in Lynch syndrome (TRIAD5-Plus): the first cross-network trial of the Cancer Prevention Clinical Trials Network (CP-CTNet). Front Immunol. 2026; 17:1809281.
-
Kunz Coyne AJ, Judd C, Lucas K, Al Musawa M, Van Helden S, Holger D, Althubyani A, Yost C, VanDorf S, Mynatt R, Kufel WD, Hayes J, Deri CR, Wrenn RH, Slaton CN, Morrisette T, Davis M, Cabanilla MG, Shald E, White BP, Sassine J, Truong J, Rosenberg J, Andrade J, Cerenzio J, Medvedeva N, Ha D, Eubank TA, Garey KW, Biagi M, Todd M, Kang-Birken SL, Rux C, Molina KC, Jankowski CA, Claeys KC, Venugopalan V, Veve MP, Orzol C, Eshaya M, Caniff KE, Bleick C, Rybak MJ. Ceftazidime-avibactam for multidrug-resistant gram-negative infections: outcomes and timing of initiation across 22 U.S. medical centers. Antimicrob Agents Chemother. 2026 Jun 03; 70(6):e0026826.
-
Denburg MR, Goodwin Davies AJ, Maltenfort MG, Mitsnefes MM, Flynn JT, Neu AM, Dixon BP, Glenn DA, Gluck CA, Harshman LA, Katsoufis CP, Leonard MB, Modi ZJ, Pan CG, Patel HP, Patterson LT, Verghese PS, Wilson AC, Jovanovska A, Levondosky R, Levondosky M, Dickinson K, Wieand K, Razzaghi H, Li L, Chen Y, Forrest CB. Comparative Effectiveness of Antihypertensive Medications in Children With Chronic Kidney Disease. JAMA Pediatr. 2026 May 01; 180(5):546-555.
-
Beukes E, Andersson G, Manchaiah V. Long-Term Outcomes of an Internet-Based Cognitive Behavior Therapy Intervention for Tinnitus: Follow-Up Analysis of a Nonrandomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2026 May 01; 152(5):503-512.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|